estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Covaryx]
RxNorm concept 705919, branded drug (sbd). Prescribable name: Covaryx 1.25 MG / 2.5 MG Oral Tablet.
- RxCUI
- 705919
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/705919 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Covaryx (estrogens, esterified (USP) 1.25 MG / methylTESTOSTERone 2.5 MG) Oral Tablet; Covaryx (estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG) Oral Tablet; estrogens, esterified (USP) 1.25 MG / methylTESTOSTERone 2.5 MG Oral Tablet [Covaryx]
Related concepts
- methyltestosterone 2.5 MG (SCDC, consists of)
- estrogens, esterified (USP) 1.25 MG (SCDC, consists of)
- estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Covaryx] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Covaryx (BN, has ingredient)
- estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 11528001001
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 705919 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/705919 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 705919. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.